2-oxindole has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enefer, S | 1 |
| Almansour, AI; Altaf, M; Antonisamy, P; Arumugam, N; Kim, HR; Kumar, RS; Kwon, KB; Periyasami, G | 1 |
| Chen, G; Ding, T; Dong, L; Fang, Q; Fu, L; Jiang, L; Liang, G; Liu, Z; Shan, X; Wang, Z; Xu, F | 1 |
| Backfisch, G; Bhowmik, S; Geneste, H; Hornberger, W; Lubisch, W; Netz, A; Oost, T; Unger, L; van Gaalen, MM; Wernet, W | 1 |
| Bloomquist, WE; Borel, AG; Cohen, ML; Droste, CA; Heiman, ML; Jesudason, CD; Kriauciunas, A; Sall, DJ; Stevens, FC; Tinsley, FC | 1 |
| Apelqvist, G; Bengtsson, F; Bergqvist, PB; Carpenedo, R; Moroni, F | 1 |
6 other study(ies) available for 2-oxindole and Disease Models, Animal
| Article | Year |
|---|---|
Inflammation 2005 - Seventh World Congress. Highlights I.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Clinical Trials, Phase I as Topic; Crohn Disease; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Drugs, Investigational; Haplorhini; Humans; Immunoglobulin G; Indoles; Inflammation; Interleukin-1; Macrophage Colony-Stimulating Factor; Mice; Multiple Sclerosis; Natalizumab; NF-kappa B; Organic Chemicals; Rats; Rats, Sprague-Dawley | 2005 |
Functionalized spirooxindole-indolizine hybrids: Stereoselective green synthesis and evaluation of anti-inflammatory effect involving TNF-α and nitrite inhibition.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Indoles; Indolizines; Models, Molecular; Molecular Structure; Nitrites; Oxindoles; Rats; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2018 |
Synthesis and biological evaluation of novel indole-2-one and 7-aza-2-oxindole derivatives as anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dose-Response Relationship, Drug; Indoles; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Oxindoles; Quantitative Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2014 |
Potent and selective oxindole-based vasopressin 1b receptor antagonists with improved pharmacokinetic properties.
Topics: Animals; Antidepressive Agents; Antidiuretic Hormone Receptor Antagonists; Disease Models, Animal; Indoles; Molecular Structure; Oxindoles; Protein Binding; Rats | 2011 |
Potent oxindole based human beta3 adrenergic receptor agonists.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Animals; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Indoles; Molecular Structure; Oxindoles; Rats; Rats, Long-Evans; Receptors, Adrenergic, beta-3; Tachycardia | 2007 |
Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: effects of systemic ammonium acetate and L-tryptophan.
Topics: Acetates; Administration, Oral; Animals; Brain; Disease Models, Animal; Hepatic Encephalopathy; Indoles; Injections, Intraperitoneal; Liver; Male; Oxindoles; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Tryptophan | 1999 |